Regulation & Compliance

Immuta's expanded Databricks partnership introduces a new security paradigm for autonomous AI, promising to turn a critical risk into a commercial advantage.

The electric boat innovator executes another reverse stock split to stay on Nasdaq, but a history of similar moves raises questions about its financial health.

xSuite's deep SAP integration and advanced AI earned it a 'Strong Performer' rank in Forrester's 2026 AP automation report, praised for high accuracy.

Northann Corp. is back in the NYSE's good graces, but a closer look reveals a risky path. Can its innovative 3D printing tech overcome financial headwinds?

BVI's new European training hub isn't just a facility; it's a response to a critical skills gap in medicine, revealing how industry is shaping our trust in healthcare.

A landmark study proves drones can safely transport human kidneys, a breakthrough that could slash wait times and save lives. But can we clear the regulatory hurdles?

A new precision drug, ART5803, is offering hope for a devastating brain disorder. Arialys Therapeutics is fast-tracking its development with key clinical trials.

Crypto exchange BingX just airdropped SpaceX 'tokens' to millions. It's a glimpse into a future of democratized investing, but the risks are very real.

A new study offers hope for MS by promoting nerve repair, but the real story is the validation of a versatile stem cell platform for a new era of medicine.

Facing a 'going concern' warning and collapsing revenue, Splash Beverage Group is ditching drinks for drugs. Its investment in Avicanna is a desperate, yet strategic, pivot.

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

AI agents can move money and update records, but who manages them? A new open-source control plane aims to give banks the trust to finally let them work.

A world-first treatment in Canada saved a young burn victim's face, bypassing devastating grafts. But can this 'miracle' therapy move from one-off to standard care?

With over 4.6% of all ETH, Bitmine is not just mining crypto; it's engineering a new kind of financial institution. Is its high-stakes strategy genius or hubris?

A merger of equals creates D.C.'s 7th largest bank. ODNB and NACB unite, promising big returns for investors and a new era for community banking.

A new breed of AI-powered software is helping businesses fight back against fraudulent reviews on Amazon, restoring trust one takedown at a time.

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Trading Technologies partners with ICE to launch a new fixed income EMS, aiming to shatter market silos with a unified multi-asset trading experience.

Praecipio's new financing arm aims to break budget logjams for Atlassian users, but does this model create new dependencies and hidden financial risks?

A new partnership aims to move beyond static risk models by integrating real-time news sentiment, giving firms a crucial edge in navigating market volatility.